Chen, Jin-Hui
Tsai, Tsen-Fang https://orcid.org/0000-0002-1498-1474
Article History
Received: 7 December 2025
Accepted: 7 April 2026
First Online: 2 May 2026
Declarations
:
: Tsen-Fang Tsai has served as a consultant for Abbvie, AnaptysBio, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli-Lilly, Galderma, GSK, Janssen-Cilag, Leo Pharma, Merck Sharp and Dohme, Novartis International, Pfizer, PharmaEssentia, Sanofi, Sun Pharma, and UCB Pharma. Jin-Hui Chen has no conflicts of interest to declare. Tsen-Fang Tsai is an Editorial Board member of Dermatology and Therapy . Tsen-Fang Tsai was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.